Seattle-based company Sana Biotechnology announced the development of an 800,000-square-foot manufacturing center in Bothell, Washington. The new facility will replace the current space in Fremont, California.
The new lease is for 16 years, with the option of three additional five-year terms and a tenant improvement allowance of up to $28 million.
“We have long viewed an internal manufacturing capability as core to our long-term success in consistently making these complex medicines at the scale and cost needed to maximize our impact,” said Steve Harr, CEO of Sana Biotechnology. “This new facility enables us to continue to develop our internal manufacturing with no anticipated impact to the timing of our programs, and in a more cost-effective manner.”